Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites
- 1 February 2007
- journal article
- Published by Cambridge University Press (CUP) in Acta Neuropsychiatrica
- Vol. 19 (1) , 45-52
Abstract
Background:: The tryptophan metabolite kynurenic acid (KYNA) is an endogenous glutamate/nicotinic receptor antagonist. Previous studies have shown that the concentration of the compound is increased in cerebrospinal fluid (CSF) of patients with schizophrenia. Furthermore, it has been found that the CSF concentration of KYNA is positively correlated to CSF concentrations of the monoamine metabolites homovanillic acid (HVA) and 5-hydroxy indoleacetic acid (5-HIAA) in healthy control subjects.Objectives:: To study the correlations between KYNA and the monoamine metabolites HVA, 5-HIAA and 4-hydroxy-3-methoxyphenylglycol (HMPG) in CSF of male patients (n= 53, ranging from 20 to 48 years of age) with verified schizophrenia.Methods:: CSF was obtained by lumbar puncture, and KYNA analysis was performed with an isocratic reversed-phase high-performance liquid chromatography system connected to a fluorescence detector. HVA, 5-HIAA and HMPG concentrations were measured by mass fragmentography with deuterium-labelled internal standards.Results:: Positive intercorrelations were found between CSF KYNA, HVA and 5-HIAA, while CSF content of HMPG did not correlate to KYNA or any of the monoamine metabolites in CSF.Conclusion:: The results of this study suggest that increased KYNA formation is associated with an increased dopamine and serotonin turnover in male patients with schizophrenia.Keywords
This publication has 72 references indexed in Scilit:
- Cerebrospinal fluid kynurenic acid in male and female controls – Correlation with monoamine metabolites and influences of confounding factorsJournal of Psychiatric Research, 2007
- Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brainJournal of Neural Transmission, 2006
- Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophreniaSchizophrenia Research, 2005
- Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSFMolecular Psychiatry, 2004
- Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acidActa Physiologica Scandinavica, 2002
- Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteersEuropean Psychiatry, 1996
- Evidence of Disturbed CSF Circulation and Brain Atrophy in Cases of Schizophrenic PsychosisThe British Journal of Psychiatry, 1984
- Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patientsActa Psychiatrica Scandinavica, 1977
- Evidence for the existence of a raphe projection to the substantia nigra in ratBrain Research, 1976
- Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic SchizophrenicsThe British Journal of Psychiatry, 1969